Sysmex enters into licensing agreement with Human Metabolome Technologies on depression biomarker

The biomarker is phosphoric acid ethanol amine (PEA) as a biomarker candidates for major depression, as discovered by HMT in cooperation with the National Center of Neurology and Psychiatry.

Nikkei Biotech news release, Sept. 29, 2015

Most popular posts: